RECMA Partnerships - PHARMACEUTICALSector Report: Merck / Schering-Plough MERCK / SCHERING-PLOUGH Currency DATE OF ADVERTISER MEDIA AGENCY INCUMBENT (Million) NORTH AMERICA
March 2010: Following the merger of Schering-Plough Corp with Merck & Co. in Nov 09, Merck Co has awarded its
MERCK & CO all
media P&B duties account ($691M) to a team of Interpublic Group agencies led by Initiative and Draftfcb (Merck
Initiative, DraftFCB
incumbents), following a consolidation review against Zenith Media and MPG. Client brands include Afrin, Claritin, Nasonex, Proventil and Dr. Scholl's. Initiative, DraftFCB
Initiative handles broadcast buying only, the rest handled by DraftFCB (342M all 09)
Merck Co has consolidated its media P&B duties account with Initiative and Draftfcb (Merck incumbents), after a consolidation review against Zenith Media and MPG, following the merger of Schering-Plough Corporation with Merck & Co. in Nov 2009. Zenith Media All buying except print for the Healthcare Div since 2001. (Claritin OTC plan & buy) + plan for Schering
SCHERING-
Lab. Zenith added buying on a new drug launched 2006, Asmanex. Initiative, DraftFCB Zenith Media
2008: Zenith added NuvaRing buying only $30m (July) from MAXUS /MindShare after a pitch and following the acquisition of parent Co Organon by Schering-Ploug in 2008. Schering acquired Intervet veterinary from Akzo Nobel in 07. Organon: Won in Oct 05 by Zenith from MEC, previously part of Akzo Nobel, acquired by Schering-Plough since Nov 2007.
MPG manages some buying and planning shared with MediaVest (for Levitra, Nasonex, Asmanex in 07 from OMD).
SCHERING-
P&B for respiratory medicines: Afrin, Coricidin- Added the planning AOR for Consumer brands in 2003. Claritin,
Initiative, DraftFCB
Coppertone, HBP, A+D, Lotrimin, Chlor-Trimeton, Miralax, Zegerid, Dr. Scholls, Tinactin, HomeAgain: P & B, Digitano broadcast
MediaVest has won planning-only assignment for Levitra, Nasonex, Asmanex end 2007 through a competitive pitch.
SCHERING- Initiative, DraftFCB MediaVest
OMD resigned the planning account for Levitra, Nasonex, after being awarded additional Eli Lilly business (plan
2009 - After a local pitch against Cossette Media (buying & some planning) and Anderson DDB Montreal (some planning) MPG Canada won the account. MPG Canada won P&B, all media, all Canada. Effective Jan. 2010 (October
SCHERING- MPG Canada Cossette Media 2009).
PHDTouch! Lost the 2 brands (Coppertone and Dr Scholl) in 2006 due to Consolidation to Cossette Media. Since 2005 Cossette Media was buying (pharma cosmetic) budget declared: $6mCAD. LATIN AMERICA SCHERING Augusto Elias
Arena won the account in November 2009 from Augusto Elias after a local pitch audited by Fairbrother. Agencies
MERCK MSD Publicidad
participating to pitch: Starcom, Carat, Universal, Augusto Elias, MindShare.
SCHERING- EuroRSCG PLOUGH SCHERING- PUERTO RICO MERCK MSD TOP 5 EUROPE John Ayling & CLARITIN ZenithOptimedia SCHERING Universal UM PLOUGH SEVEN SEAS HEALTHCARE RECMA Partnerships - PHARMACEUTICALSector Report: Merck / Schering-Plough Currency DATE OF ADVERTISER MEDIA AGENCY INCUMBENT (Million) INTERVET
part of Schering-Plough, Merck KGaA Group.
LAB. MYLAN SCHERING- Carat, Vizeum
2009: After pitch against Carat MPG won Merck account. 2008: Vizeum managed the "Ilvico" Campaign. WESTERN EUROPE PORTUGAL Executive Media MERCK SHARP & CENTRAL EASTERN EUROPE SCHERING- Initiative MEDEA-MPG REPUBLIC SCHERING- Starcom, Maximize SCHERING - Media Investment OMD Media SCHERING- APR Media Services Direction, FEDERATION PLOUGH
from OMD Media Direction: Claritin brand only
MIDDLE EAST MSD INDIA & SOUTHEAST ASIA SCHERING- ZenithOptimedia PHILIPPINES MERCK SHARPE &
Vizeum had a 1 year deal for 2008 only, the account then moved to PHD.
Decl. amount $1m, won in partnership with creative agency
INDONESIA Initiative ZenithOptimedia GREATER CHINA SCHERING- Zenith Media Mindshare AUSTRALASIA SCHERING ZenithOptimedia
OMD won from MEC in 2006. But then lost it to ZenithOptimedia in 2007 november
AUSTRALIA MERCK SHARP &
THE SAFE ANSWER TO HORMONAL IMBALANCE, PMS, Note: This brief and easy to understand booklet explores the uses of natural prog-esterone for a myriad of symptoms women continually endure assuming thattheir only option is synthetic hormone therapy. Issues pertaining to menstrualdisorders, PMS, fibrocystic breasts, menopausal miseries, osteoporosis, and can-cer are discussed supporting the use of
MAE TAO CLINIC Medication and Supplies Wish list for Donors Updated July 2011 The clinic utilizes a comprehensive list of medications that are consistent with the published Burma Border Guidelines. The list below consists of items that are considered of high priority to the clinic and its patients. Most of these items can be purchased in Thailand, and usually at a significantly lower pric